CVM Orders Centaurus to Launch Full Tender Offer for Oncoclínicas

Overview

• The CVM colegiado this week instructed Centaurus to complete a mandatory public tender offer covering all shareholders within 60 days, with the compliance clock running from August 25.
• The regulator fixed November 4, 2024 as the fact‑generator date and required the offer price to be updated by the Selic rate from that date to settlement, which boosts the final payout beyond prior market estimates.
• Market calculations reported by Valor show the required cash could climb toward roughly R$11.7 billion, far above earlier estimates of about R$6–6.5 billion, as Selic accrual and the statutory pricing formula are applied.
• Centaurus has filed arbitration at B3/CAM against Latache contesting aspects of the OPA, and minority shareholders are organizing judicial actions to press the operation forward, creating parallel legal risks to timing and execution.
• Oncoclínicas is negotiating an extrajudicial recovery for about R$5.1 billion of debt with proposed haircuts up to 80%, a financial backdrop that shapes shareholder incentives and the economic logic of any buyout.